This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated CDK8 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-CDK8 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~53.3 kDa | |
| Observed band | 53 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | — | |
| Caveat | Alternative splicing isoforms | |
| Regulation | Apical junction | |
| Isoform | 2 isoform(s) |
Literature-validated Western blot parameters for CDK8 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human Hela , Lane 2: human K562 , Lane 3: human Jurkat , Lane 4: human Caco-2 , Lane 5: human HEK293 . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-CDK8 antigen affinity purified polyclonal antibody (Catalog # A01493-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for CDK8 at approximately 53 kDa. The expected band size for CDK8 is at 53 kDa |
| Gel % | 10–12% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 53 kDa |
CDK8 has a 53.3 kDa predicted mass and runs at the matching 53 kDa observed band, since it lacks glycosylation, disulfides, or cleavage events that would shift its size.
| single sharp band at ~53 kDa | matches the predicted CDK8 monomer mass with no glycosylation, disulfide crosslinking, or precursor cleavage to shift mobility |
| faint doublet or closely spaced second band near 53 kDa | reflects co-expression of the two annotated CDK8 splice isoforms (1 and 2) |
| signal present in nuclear or whole-cell lysate | consistent with CDK8's nuclear localization as a kinase module component of the Mediator complex |
| no very high-molecular-weight band near the intact Mediator complex size | the Mediator complex is held together non-covalently and dissociates under denaturing SDS-PAGE, so CDK8 runs as a free monomer |
| no diffuse high-molecular-weight smear above 53 kDa | CDK8 has no annotated glycosylation sites, so heterogeneous glycoform smearing is not expected |
| Predicted mass (53.3 kDa) | sets the baseline migration position, which matches the empirically observed 53 kDa band closely |
| Alternative splicing (isoforms 1 and 2) | can yield a minor secondary band or doublet if both isoforms are co-expressed, though no distinct per-isoform mass is defined |
| Mediator complex association (non-covalent) | does not add apparent mass on a denaturing gel because SDS-PAGE dissociates the complex, leaving CDK8 as a monomer |
| Nuclear localization | keeps CDK8 retained in nuclear/whole-cell lysates rather than depleted into secreted fractions, supporting consistent signal |
| Absence of glycosylation and disulfide modifications | keeps the band sharp and single rather than smeared or shifted upward |
| Situation | Likely cause | Next action |
|---|---|---|
| Multiple bands | detection of both annotated splice isoforms 1 and 2, or non-specific antibody cross-reactivity | compare band pattern across cell lines and confirm specificity with a knockdown or knockout control |
| Band higher than expected | incomplete denaturation leaving residual Mediator complex or aggregate interactions intact | ensure thorough boiling and reducing sample preparation with fresh denaturing loading buffer |
| Band lower than expected | proteolytic degradation during nuclear lysate preparation, since CDK8 has no protective modifications like glycosylation | add protease inhibitors and keep lysates cold throughout nuclear extraction |
| Weak or no signal | low endogenous CDK8 expression or incomplete solubilization of the nuclear compartment | use a dedicated nuclear extraction or RIPA buffer with sonication to fully release nuclear protein |
| No band in lysate | cytoplasmic-only fractionation that excludes the nuclear pool where CDK8 resides | switch to whole-cell lysis or a nuclear extraction protocol to capture nuclear CDK8 |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for CDK8, answered from its protein features.
BosterBio's CDK8 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
The recommended anti-CDK8 antibodies below are top-performing, highly cited reagents for Western blot, rigorously validated with clear specific bands and cross-checked against negative tissue and complementary detection methods to confirm target specificity.
Which to pick: Only one CDK8 antibody is catalogued, A01493-1, which includes an actual Western blot validation image showing a specific band, so it is the one to use for your CDK8 WB experiments.